Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Chloroquine → (2S)-2-methyl-N-((S)-1-phenylethyl)octanamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Chloroquine | HCID 2719 | — |
| 반응물 | Amphotericin B | HCID 5280965 | — |
| 반응물 | Nifurtimox | HCID 6842999 | — |
| 생성물 | (2S)-2-methyl-N-((S)-1-phenylethyl)octanamide | HCID 46237307 | — |
반응 단계
Bioassays. All bioassays were performed in duplicate, testing at 10, 2, 0.4, 0.08 and 0.016 μg/mL. Malaria bioassays were performed as previously reported by our program, using chloroquine as a positive control (IC50=80-100 nM). Chagas bioassays were performed following the protocol of Buckner et al, and using nifurtimox as a positive control (IC50 3-5 μg/mL). Leishmaniasis bioassays were performed using a method previously employed in our laboratory, based on parasite DNA fluorescence. In this latter assay, amphotericin-B was used as the positive control and had an IC50 value of 80 ng/mL. Cytotoxicity bioassays were performed following an MTT cell proliferation assay protocol with green monkey Vero kidney cells.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09321811B2 |
| 출처 데이터셋 | uspto-grants-2016_04 |
| ORD ID | ord-d5698f8c8111443ab472a715ce2a2ac4 |
| 출처 메모 | uspto-grants-2016_04 |